Hepatocellular (Liver) Cancer

Cat 1 · 30 days

appointment within 30 calendar days. - Patients with a history of cirrhosis of the liver from any cause or history of hepatitis B for monitoring / screening for the development of Hepatocellular carcinoma should be referred to the Gastroenterology / Hepatology service. [https://www.health.qld.gov.au/cpc/general-surgery/hepatobiliary-surgery] - Patients with suspected primary Liver cancer should be referred to the Hepatology / Gastroenterology team for evaluation and further investigation. Patients are usually then presented in a multi-disciplinary meeting for treatment planning and further referral if required for Medical Oncology input. [https://www.health.qld.gov.au/cpc/general-surgery/hepatobiliary-surgery] - Patients are usually referred from the MDT meeting after thorough evaluation for appropriate therapies such as Transplant, surgery, Trans-arterial chemo-embolisation, Stereotactic body radiotherapy, Radiologically guided ablation techniques, or Systemic therapies. - Patients for Trans-arterial chemo-embolisation therapy prior to surgery or as primary management (usually referred by the Hepatologist or Surgeon after MDT), for optimum care, patient should be seen within 4 weeks. - Metastatic or Multifocal hepatocellular cancer (De novo or following prior treatment for known disease) and has tissue confirmation (usually referred by the Hepatologist or Surgeon after MDT)

Cat 2 · 90 days

appointment within 90 calendar days. - Transfer of care from another health service

Cat 3 · 365 days

appointment within 365 calendar days. - No category 3 criteria